Vectura licences drug to Glaxo for £20m | Alrroya

Vectura licences drug to Glaxo for £20m

Friday, 6 August 2010  at  11:26, Bloomberg
Vectura Group Plc licensed some of its dry powder drug formulation patents to GlaxoSmithKline Plc for as much as £20 million in upfront payments, the company said on Friday in a statement.








Your comments

The content of this field is kept private and will not be shown publicly.
  • Allowed HTML tags: <b> <i> <a> <em> <strong> <cite> <code> <ul> <ol> <li> <dl> <dt> <dd>
  • Lines and paragraphs break automatically.
  • Web page addresses and e-mail addresses turn into links automatically.

More information about formatting options

  • Subscribe to Daily Newsletter More

  • Join Alrroya.com